Bayer HealthCare Licenses Genomatix’ Microarray Analysis Platform ChipInspector
News May 24, 2006
ChipInspector is designed to enable biologists and bio-informaticians to analyze chip raw data from Affymetrix GeneChip and Exon Arrays.
It employs a proprietary single probe approach based on latest genomic annotation from Genomatix' ElDorado annotation pipeline.
Starting with ChipInspector the Genomatix Microarray Analysis Pipeline integrates literature and pathway mining as well as promoter analysis on sequence level in one coherent system.
"After several successful pilot studies we are now very pleased that Bayer HealthCare licensed ChipInspector," states Dr. Martin Seifert, VP Microarray business and collaborative research.
"We expect that ChipInspector will enhance the Affymetrix analysis pipeline starting from GeneChip and Exon Arrays at Bayer."
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.